Published in Rev Pneumol Clin on November 18, 2008
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med (1998) 7.08
Epidural corticosteroid injections for sciatica due to herniated nucleus pulposus. N Engl J Med (1997) 5.17
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J (2010) 2.90
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension. Eur Respir J (1998) 2.14
Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax (2005) 2.03
Primary pulmonary hypertension and fenfluramine use. Br Heart J (1993) 2.02
High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest (1999) 1.70
Thrombotic risk factors in pulmonary hypertension. Eur Respir J (2000) 1.54
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J (2007) 1.51
Diagnosis and management of subsegmental pulmonary embolism. J Thromb Haemost (2006) 1.47
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med (1995) 1.46
[Evaluation of preoperative non-invasive ventilation in thoracic surgery for lung cancer: the preOVNI study GFPC 12-01]. Rev Mal Respir (2012) 1.39
Long term imatinib treatment in pulmonary arterial hypertension. Thorax (2006) 1.32
Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study. Fundam Clin Pharmacol (2007) 1.27
Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation (1994) 1.24
Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med (2000) 1.23
Pollen-based quantitative reconstructions of Holocene regional vegetation cover (plant-functional types and land-cover types) in Europe suitable for climate modelling. Glob Chang Biol (2014) 1.21
Risk factors for pulmonary arterial hypertension. Clin Chest Med (2001) 1.20
Pathobiology of pulmonary hypertension. The role of platelets and thrombosis. Clin Chest Med (2001) 1.11
Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study. J Thromb Haemost (2007) 1.09
Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation (1996) 1.07
[Education of the adult asthmatic]. Rev Mal Respir (2002) 1.06
Three-dimensional measurement of wedged scoliotic vertebrae and intervertebral disks. Eur Spine J (1998) 1.01
Is obesity associated with injuries among young people? Eur J Epidemiol (2004) 1.01
Morphometric evaluations of personalised 3D reconstructions and geometric models of the human spine. Med Biol Eng Comput (1997) 0.98
Acylation and immunological properties of Mycoplasma gallisepticum membrane proteins. Res Microbiol (1996) 0.97
Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study. J Thromb Haemost (2006) 0.97
Allergic bronchopulmonary aspergillosis and omalizumab. Allergy (2011) 0.97
[Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients]. J Mal Vasc (2010) 0.96
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics. Allergy (2009) 0.94
Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med (1997) 0.91
Purification and characterization of a membrane glycoprotein from the fish pathogen Flavobacterium psychrophilum. J Appl Microbiol (2003) 0.91
Evaluation of a new, rapid, and quantitative D-Dimer test in patients with suspected pulmonary embolism. Am J Respir Crit Care Med (1998) 0.90
Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation. J Heart Lung Transplant (1997) 0.90
[Surgical treatment of chronic thromboembolic pulmonary hypertension]. Presse Med (2005) 0.89
Selective acylation of plasma membrane proteins of Mycoplasma mycoides subsp. mycoides SC, the contagious bovine pleuropneumonia agent. Curr Microbiol (1996) 0.88
Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different. Eur Respir J (2012) 0.88
Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma. Ann Oncol (2010) 0.87
Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost (2014) 0.87
Cross-sectional assessment of workers with repeated exposure to chlorine over a three year period. Eur Respir J (1995) 0.87
Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline. J Mal Vasc (2009) 0.86
Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J (2006) 0.86
Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy. Am J Respir Crit Care Med (2001) 0.85
The association between resting and mild-to-moderate exercise pulmonary artery pressure. Eur Respir J (2011) 0.85
[A case of a carcinoid tumour presenting as an "upper lobe syndrome"]. Rev Mal Respir (2011) 0.84
The Flavobacterium psychrophilum OmpA, an outer membrane glycoprotein, induces a humoral response in rainbow trout. J Appl Microbiol (2007) 0.84
Fatal congenital tuberculosis due to a Beijing strain in a premature neonate. J Med Microbiol (2010) 0.84
Fenfluramine-like cardiovascular side-effects of benfluorex. Eur Respir J (2009) 0.84
Education and self-management: a one-year randomized trial in stable adult asthmatic patients. J Asthma (2002) 0.84
Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the 27 European Union member states. Ann Oncol (2013) 0.83
Inhibition of spiralin processing by the lipopeptide antibiotic globomycin. Curr Microbiol (1996) 0.83
Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study. Eur Respir J (1999) 0.83
Longitudinal assessment of airway caliber and responsiveness in workers exposed to chlorine. Am J Respir Crit Care Med (1999) 0.82
Evaluation of a new rapid D-dimer assay for clinically suspected deep venous thrombosis (Liatest D-dimer). Am J Clin Pathol (1998) 0.82
[Pulmonary complications in adult sickle cell disease]. Rev Mal Respir (2011) 0.81
Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study Group. Haemostasis (1999) 0.81
The value of a risk factor analysis in clinically suspected deep venous thrombosis. Respiration (1997) 0.81
Expression of foreign genes and selection of promoter sequences in Acholeplasma laidlawii. Microbiology (1995) 0.81
Usefulness of omalizumab in ten patients with severe occupational asthma. Allergy (2013) 0.80
Identification of bacterial periplasmic glycine betaine-binding protein after electrophoresis and affinity labeling. J Biochem Biophys Methods (1991) 0.80
Chlamydia pneumoniae IgG serological status and venous thromboembolism: a cross-sectional hospital based study. Presse Med (2004) 0.80
Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy (2007) 0.80
Identification of P18, a surface protein produced by the fish pathogen Flavobacterium psychrophilum. J Appl Microbiol (2004) 0.78
Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy. Eur Respir J (2009) 0.78
[Calf muscle venous thrombosis and pulmonary embolism]. J Mal Vasc (1999) 0.78
[Hypersensitivity pneumonitis in a patient taking pravastatin]. Rev Mal Respir (2001) 0.78
Chronic thromboembolic pulmonary hypertension: a tribute to pulmonary endarterectomy. Eur Respir J (2009) 0.78
Quantification of Flavobacterium psychrophilum in rainbow trout, Oncorhynchus mykiss (Walbaum), tissues by qPCR. J Fish Dis (2011) 0.78
Biochemical and antigenic characterisation of Mycoplasma gallisepticum membrane proteins P52 and P67 (pMGA). Arch Microbiol (2001) 0.78
[Optimal duration of anticoagulation of venous thromboembolism]. J Mal Vasc (2011) 0.78
[Thrombosis and lung cancer]. Rev Pneumol Clin (2008) 0.78
Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre. Eur Respir Rev (2009) 0.78
Quantification of CFTR splice variants in adults with disseminated bronchiectasis, using the TaqMan fluorogenic detection system. Clin Genet (2002) 0.78
Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis. Eur Respir J (2002) 0.77
Blood pressure measurement in epidemiological investigations in teenagers. Eur J Epidemiol (2001) 0.77
[Pulmonary hypertension and obesity]. Rev Pneumol Clin (2002) 0.77
Differences in clinical presentation of pulmonary embolism in women and men. J Thromb Haemost (2010) 0.77
[Pulmonary embolism and the level of thrombosis. A prospective study of 155 patients]. Rev Mal Respir (1995) 0.77
[Pulmonary arterial hypertension due to tumor emboli]. Rev Mal Respir (2007) 0.76
Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease. Respiration (2000) 0.76
Kinematic modeling for the assessment of wheelchair user's stability. IEEE Trans Neural Syst Rehabil Eng (2001) 0.76
[Pulmonary hypertension complicating systemic diseases other than connective tissue diseases]. Presse Med (2003) 0.75
[Discovery of a yellow nail syndrome with major hypothyroidism]. Rev Pneumol Clin (2012) 0.75
Lithium concentrations during cisplatin-based chemotherapy: evidence for renal interaction. Cancer Chemother Pharmacol (1995) 0.75
[Multiple free transplants in reconstructive surgery]. Presse Med (1995) 0.75
[Pulmonary arterial hypertension of chronic thromboembolic origin; therapeutic indications]. Arch Mal Coeur Vaiss (1994) 0.75
Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolism. Am J Hematol (1995) 0.75
[Post-embolic pulmonary arterial hypertension: therapeutic indications]. Cardiologia (1995) 0.75
[Chronic pulmonary heart disease: therapeutic indications]. Arch Mal Coeur Vaiss (1995) 0.75
[Complete reconstruction of the nose using a prefabricated free forearm graft]. Chirurgie (1994) 0.75
[Pulmonary arterial hypertension in the elderly subject]. Rev Mal Respir (2009) 0.75
[Multiple free transplants in microsurgery for cervicofacial reconstruction]. Chirurgie (1996) 0.75
Vitamin K metabolism in a patient resistant to vitamin K antagonists. Haemostasis (1998) 0.75